AVNS - Avanos Medical Non-GAAP EPS of $0.27 misses by $0.01 revenue of $191.7M misses by $3.5M
2023-05-03 07:11:52 ET
- Avanos Medical press release ( NYSE: AVNS ): Q1 Non-GAAP EPS of $0.27 misses by $0.01 .
- Revenue of $191.7M (-2.9% Y/Y) misses by $3.5M .
- The company affirms previous guidance for 2023 and anticipates low single-digit organic growth. Additionally, the company expects operating profit margin and EBITDA margin expansion of approximately 100 basis points and adjusted diluted earnings per share of between $1.60 and $1.80 vs. consensus of $1.70.
For further details see:
Avanos Medical Non-GAAP EPS of $0.27 misses by $0.01, revenue of $191.7M misses by $3.5M